Veeco launches Lumina+ MOCVD system, receives Rocket Lab order
LONDON - Craneware plc (AIM:CRW.L), a provider of healthcare financial performance solutions, reported a 9% increase in revenue to $205.7 million for the fiscal year ended June 30, 2025, according to a company press release issued Monday.
The U.S. healthcare software provider saw its annual recurring revenue grow 7% to $184 million, with net revenue retention improving to 107% from 98% in the previous year. Adjusted EBITDA rose 12% to $65.3 million, representing a margin of 32%.
Statutory profit before tax increased 52% to $24 million, benefiting from reduced finance costs. The company’s cash position strengthened to $55.9 million, up from $34.6 million at the end of fiscal 2024, while bank debt was reduced to $27.7 million from $35.4 million.
Craneware proposed a final dividend of 18.5 pence per share, bringing the total dividend for the year to 32 pence per share, a 10% increase from the previous year.
The company reported customer retention of over 90% and said it had completed integration of all customer-facing teams across its offerings. Its Trisus Chargemaster product received Microsoft’s "AI for Healthcare" certification and was awarded "Best in KLAS."
Following the end of the fiscal year, Craneware secured a new $100 million unsecured revolving credit facility for three years, with an option to extend for two additional one-year terms and an additional $100 million accordion facility.
"FY25 was a proud milestone, not just due to the strength of the financial performance, but for what that growth represents: the tireless efforts by our team in the service of our hospital customers and the communities they serve," said Keith Neilson, CEO of Craneware.
The company indicated that trading in the first months of the new fiscal year has started well, providing confidence for continued growth acceleration in fiscal 2026.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.